176 related articles for article (PubMed ID: 11569695)
1. Biological variability of fecal calprotectin in patients referred for colonoscopy without colonic inflammation or neoplasm.
Husebye E; Tøn H; Johne B
Am J Gastroenterol; 2001 Sep; 96(9):2683-7. PubMed ID: 11569695
[TBL] [Abstract][Full Text] [Related]
2. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy.
Limburg PJ; Ahlquist DA; Sandborn WJ; Mahoney DW; Devens ME; Harrington JJ; Zinsmeister AR
Am J Gastroenterol; 2000 Oct; 95(10):2831-7. PubMed ID: 11051356
[TBL] [Abstract][Full Text] [Related]
3. A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method.
Johne B; Kronborg O; Tøn HI; Kristinsson J; Fuglerud P
Scand J Gastroenterol; 2001 Mar; 36(3):291-6. PubMed ID: 11305517
[TBL] [Abstract][Full Text] [Related]
4. Fecal calprotectin as a predictor of abnormal colonic histology.
Shitrit AB; Braverman D; Stankiewics H; Shitrit D; Peled N; Paz K
Dis Colon Rectum; 2007 Dec; 50(12):2188-93. PubMed ID: 17963005
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia.
Limburg PJ; Devens ME; Harrington JJ; Diehl NN; Mahoney DW; Ahlquist DA
Am J Gastroenterol; 2003 Oct; 98(10):2299-305. PubMed ID: 14572583
[TBL] [Abstract][Full Text] [Related]
6. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
Kolho KL; Raivio T; Lindahl H; Savilahti E
Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
[TBL] [Abstract][Full Text] [Related]
7. Fecal calprotectin: assessment of a rapid test.
Vestergaard TA; Nielsen SL; Dahlerup JF; Hornung N
Scand J Clin Lab Invest; 2008; 68(4):343-7. PubMed ID: 17852834
[TBL] [Abstract][Full Text] [Related]
8. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.
Kallel L; Ayadi I; Matri S; Fekih M; Mahmoud NB; Feki M; Karoui S; Zouari B; Boubaker J; Kaabachi N; Filali A
Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):340-5. PubMed ID: 19581809
[TBL] [Abstract][Full Text] [Related]
9. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
Fagerberg UL; Lööf L; Lindholm J; Hansson LO; Finkel Y
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):414-20. PubMed ID: 18030206
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: A multicenter prospective study.
Meucci G; D'Incà R; Maieron R; Orzes N; Vecchi M; Visentini D; Minoli G; Dal Pont E; Zilli M; Benedetti E; Virgilio T; Tonutti E
Dig Liver Dis; 2010 Mar; 42(3):191-5. PubMed ID: 19695969
[TBL] [Abstract][Full Text] [Related]
11. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.
Johnson MW; Maestranzi S; Duffy AM; Dewar DH; Forbes A; Bjarnason I; Sherwood RA; Ciclitira P; Nicholls JR
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):174-9. PubMed ID: 18301296
[TBL] [Abstract][Full Text] [Related]
12. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H
Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166
[TBL] [Abstract][Full Text] [Related]
13. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease.
Bunn SK; Bisset WM; Main MJ; Gray ES; Olson S; Golden BE
J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):14-22. PubMed ID: 11479402
[TBL] [Abstract][Full Text] [Related]
14. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.
Scarpa M; D'Incà R; Basso D; Ruffolo C; Polese L; Bertin E; Luise A; Frego M; Plebani M; Sturniolo GC; D'Amico DF; Angriman I
Dis Colon Rectum; 2007 Jun; 50(6):861-9. PubMed ID: 17473939
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of calprotectin level in intestinal content as an early marker for graft rejection.
Cagnola H; Scaravonati R; Cabanne A; Bianchi C; Gruz F; Errea A; Zambernardi A; Meier D; Chirdo F; Docena G; Gondolesi G; Rumbo M
Transplant Proc; 2010; 42(1):57-61. PubMed ID: 20172281
[TBL] [Abstract][Full Text] [Related]
16. [Calprotectin levels in patients with idiopathic inflammatory bowel disease comparison of two commercial tests].
Malícková K; Janatková I; Bortlík M; Komárek V; Lukás M
Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):147-53. PubMed ID: 19069028
[TBL] [Abstract][Full Text] [Related]
17. Fecal calprotectin in very low birth weight infants.
Josefsson S; Bunn SK; Domellöf M
J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):407-13. PubMed ID: 17414135
[TBL] [Abstract][Full Text] [Related]
18. Fecal calprotectin in clinical practice: a noninvasive screening tool for patients with chronic diarrhea.
Licata A; Randazzo C; Cappello M; Calvaruso V; Butera G; Florena AM; Peralta S; Cammà C; Craxì A
J Clin Gastroenterol; 2012 Jul; 46(6):504-8. PubMed ID: 22565607
[TBL] [Abstract][Full Text] [Related]
19. Fecal excretion of calprotectin in colorectal cancer: relationship to tumor characteristics.
Kristinsson J; Armbruster CH; Ugstad M; Kriwanek S; Nygaard K; Tøn H; Fuglerud P
Scand J Gastroenterol; 2001 Feb; 36(2):202-7. PubMed ID: 11252414
[TBL] [Abstract][Full Text] [Related]
20. Faecal calprotectin in the assessment of Crohn's disease activity.
Gaya DR; Lyon TD; Duncan A; Neilly JB; Han S; Howell J; Liddell C; Stanley AJ; Morris AJ; Mackenzie JF
QJM; 2005 Jun; 98(6):435-41. PubMed ID: 15879440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
